<DOC>
	<DOCNO>NCT02066649</DOCNO>
	<brief_summary>Subjects individual great 18 year age diagnosis cirrhosis undergo screen esophageal varix . Eligible subject diagnosis cirrhosis esophageal varix ( grade medium large ) prior history variceal bleeding . The diagnosis cirrhosis base clinical , radiologic , and/or laboratory data . Patients randomly assign use electronic medical record one three treatment arm screen esophagogastroduodenoscopy ( EGD ) perform large varix identify . Primary outcome study incidence variceal bleed patient receive one follow therapy primary prophylaxis variceal bleeding : carvedilol , variceal band ligation ( VBL ) , carvedilol VBL .</brief_summary>
	<brief_title>Carvedilol v Band Ligation v Combination Therapy Primary Prophylaxis Variceal Bleeding</brief_title>
	<detailed_description>Inclusion criterion study individual &gt; 18 year old diagnosis cirrhosis ( either history , serology image ) , medium large esophageal varix variceal screen esophagogastroduodenoscopy ( EGD ) , prior history gastrointestinal ( GI ) bleeding , related portal hypertension . Exclusion criterion follow : pregnant female ; patient beta blocker nitrate underlie condition ; allergy carvedilol ; mean arterial pressure &lt; 55 mm Hg pulse &lt; 55 beat per minute baseline ; presence hepatocellular carcinoma ; presence portal vein thrombosis ; patient severe , uncontrolled respiratory disease ( asthma , COPD ) ; patient complete heart block significant arrhythmia ; significant renal disease ( CKD stage III high ) ; patient unable provide consent ; patient opinion principal investigator suitable participation trial . Patients randomize one follow three treatment group : ( 1 ) carvedilol group , ( 2 ) variceal band ligation ( 3 ) combination therapy ( carvedilol plus variceal band ligation ) . Since standard care University Hospital use beta blocker medication , carvedilol group serve control group . After consent obtain EGD research study patient meet non-endoscopic inclusion exclusion criterion mention , undergo screen EGD look varix . Varices grade 2-group classification system `` small '' `` large '' . Varices grade large &gt; 5mm small &lt; 5mm size . A biopsy forceps insert biopsy channel gastroscope open . An open biopsy forceps measure approximately 5mm diameter . This used measure size varix confirm two physician . If patient find small esophageal varix , exclude study manage per standard care . Once patient identify large esophageal varix , undergo randomization initial endoscopy . A random number generator use randomize patient one three treatment group describe . If patient randomize carvedilol group , endoscopic procedure terminate patient give prescription carvedilol time discharge . He follow Gastroenterology clinic regular fashion medication titrate symptom assess . If patient randomize variceal band ligation group , patient undergo band esophageal varix Wilson-Cook multi-banding device . He/she start proton-pump inhibitor post-procedure minimize risk post-banding ulcer , know complication variceal banding . Once patient treat VBL , procedure schedule repeat every two week obliteration varix ( ie varix detect endoscopy ) . The first surveillance EGD obliteration perform 1-3 month obliteration every 6 month check variceal recurrence . If patient randomize combination group , patient undergo band protocol describe . The patient give prescription carvedilol proton-pump inhibitor discharge follow clinic schedule .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Inclusion criterion study individual &gt; 18 year old diagnosis cirrhosis ( either history , serology image ) , medium large esophageal varix variceal screen esophagogastroduodenoscopy ( EGD ) , prior history gastrointestinal ( GI ) bleeding , related portal hypertension Exclusion criterion follow : pregnant female ; patient beta blocker nitrate underlie condition ; allergy carvedilol ; mean arterial pressure &lt; 55 mm Hg pulse &lt; 55 beat per minute baseline ; presence hepatocellular carcinoma ; presence portal vein thrombosis ; patient severe , uncontrolled respiratory disease ( asthma , COPD ) ; patient complete heart block significant arrhythmia ; significant renal disease ( CKD stage III high ) ; patient unable provide consent ; patient opinion principal investigator suitable participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>portal hypertension</keyword>
	<keyword>esophageal varix</keyword>
	<keyword>variceal bleed</keyword>
	<keyword>carvedilol</keyword>
	<keyword>variceal band ligation</keyword>
</DOC>